stromal :访

Yoichi Naito1, Shiro Iwagami2,3, Toshihiko Doi4

  • 1Department of General Internal Medicine, Medical Oncology, Experimental Therapeutics, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-shi, Chiba-ken, Kashiwa, 277-8577, Japan. ynaito@east.ncc.go.jp.

概括

皮米特斯皮布在日本患者中证明了安全性和有效性,这些患者患有晚期胃肠道瘤 (GIST). 这种热冲击蛋白90抑制剂在现实实践中显示了4.2个月的中位数无进展生存期.